Your browser doesn't support javascript.
loading
IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model.
Surana, Rishi; Wang, Shangzi; Xu, Wei; Jablonski, Sandra A; Weiner, Louis M.
Afiliación
  • Surana R; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Wang S; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Xu W; Department of Pathology, Georgetown University Medical Center, Washington, District of Columbia.
  • Jablonski SA; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Weiner LM; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia. weinerl@georgetown.edu.
Cancer Immunol Res ; 2(11): 1103-12, 2014 Nov.
Article en En | MEDLINE | ID: mdl-25204776

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interleucina-4 / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2014 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interleucina-4 / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2014 Tipo del documento: Article